Evangelos Bournakis - Concepedia

Author

Evangelos Bournakis

National and Kapodistrian University of Athens

Also Known As

Bournakis, E., E Bournakis, E. Bournakis, EVANGELOS BOURNAKIS, Evangelos Bournakis, Frank Griesinger

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Alexandra Hospital Metropolitan Hospital University Hospital of Ioannina Papageorgiou General Hospital

About

Evangelos Bournakis is an author at National and Kapodistrian University of Athens specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	741
2	Cell Biology	2	2	91
3	Health Sciences	1	1	50
4	Public Health	1	1	119
5	Immunology	1	1	50

Evangelos Bournakis

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial Christopher J. Sweeney, Sergio Bracarda, Cora N. Sternberg, The Lancet UrologyOncologyGenitourinary CancerMedicineClinical Trials	2021	313
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study Florentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou, Breast Cancer Research and Treatment Brca1 MutationsBreast OncologyCancer EpidemiologyMedicineGenetics	2012	119
Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum‐paclitaxel chemotherapy Aristotle Bamias, Maria Sotiropoulou, Dimitrios Haidopoulos, Cancer	2010	88
Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer Martha Zavridou, Αreti Strati, Evangelos Bournakis, Cancers	2021	85
Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab Anna G. Antonacopoulou, Anastasia G Eleftheraki, Foteinos‐Ioannis Dimitrakopoulos, The Pharmacogenomics Journal MedicineColorectal CancerPathologyColorectal Cancer PatientsIrinotecan-based Chemotherapy	2011	75
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study Amanda Psyrri, Konstantine T. Kalogeras, Ralf Kronenwett, Annals of Oncology	2011	75
Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival Constantinos Giaginis, Nikolaos Tsoukalas, Evangelos Bournakis, BMC Clinical Pathology	2014	70
Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer Flora Zagouri, Evangelos Bournakis, Konstantinos Koutsoukos, Pharmaceuticals Tumor BiologyBreast OncologyProtein ExpressionMedicineCancer Cell Biology	2012	68
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem‐cell transplantation: Results of a single institution, randomized phase 2 trial Evangelos Eleutherakis‐Papaiakovou, Evangelos Kostis, Magdalini Migkou, American Journal of Hematology Transplantation MedicineImmunologyAutologous Stem‐cell TransplantationDrug ResistanceProphylactic Antibiotics	2010	50
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study George Pentheroudakis, Anna Batistatou, Konstantine T. Kalogeras, Breast Cancer Research and Treatment Breast OncologyCancer RiskEarly Breast CancerMedicineβ-Tubulin Isotype Iii	2011	38

Page 1